Access Biotechnology
Overview
Access Biotechnology is the life science investment arm of Access Industries, investing in both private and public biopharma companies developing transformative therapies for conditions with high unmet needs.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Treeline Biosciences | Sep 2025 | Series A | Co-investor |
| Day One Biopharmaceuticals | Aug 2024 | Private Placement | Co-investor |
| Hemab Therapeutics | Oct 2025 | Series C | Co-investor |
| Surrozen | Mar 2025 | Private Placement | Co-investor |
| GRO Biosciences | Jul 2024 | Series B | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Access Biotechnology based?
Access Biotechnology is headquartered in New York City, New York, United States.
When was Access Biotechnology founded?
Access Biotechnology was founded in 2019.
How many portfolio companies does Access Biotechnology have?
Access Biotechnology has 18 portfolio companies in Caplight's dataset.
What are some companies in Access Biotechnology's portfolio?
Portfolio companies visible on Caplight include Treeline Biosciences, Day One Biopharmaceuticals, Hemab Therapeutics, Surrozen, GRO Biosciences.
What was Access Biotechnology's most recent investment shown here?
Access Biotechnology's most recent investment in this portfolio sample was in Hemab Therapeutics in 2025.
What sectors does Access Biotechnology focus on?
Access Biotechnology focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Access Biotechnology focus on?
Access Biotechnology typically invests at the Early stage.